nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—PDE4C—forebrain—attention deficit hyperactivity disorder	0.0968	0.157	CbGeAlD
Roflumilast—PDE4C—midbrain—attention deficit hyperactivity disorder	0.0639	0.104	CbGeAlD
Roflumilast—PDE4C—nervous system—attention deficit hyperactivity disorder	0.0525	0.0852	CbGeAlD
Roflumilast—PDE4C—central nervous system—attention deficit hyperactivity disorder	0.0506	0.082	CbGeAlD
Roflumilast—PDE4B—forebrain—attention deficit hyperactivity disorder	0.0449	0.0729	CbGeAlD
Roflumilast—PDE4D—cerebellum—attention deficit hyperactivity disorder	0.0435	0.0706	CbGeAlD
Roflumilast—PDE4C—brain—attention deficit hyperactivity disorder	0.0402	0.0651	CbGeAlD
Roflumilast—PDE4A—cerebellum—attention deficit hyperactivity disorder	0.0385	0.0624	CbGeAlD
Roflumilast—PDE4D—brain—attention deficit hyperactivity disorder	0.0353	0.0573	CbGeAlD
Roflumilast—PDE4A—brain—attention deficit hyperactivity disorder	0.0313	0.0507	CbGeAlD
Roflumilast—PDE4B—midbrain—attention deficit hyperactivity disorder	0.0297	0.0481	CbGeAlD
Roflumilast—PDE4B—nervous system—attention deficit hyperactivity disorder	0.0244	0.0396	CbGeAlD
Roflumilast—PDE4B—central nervous system—attention deficit hyperactivity disorder	0.0235	0.0381	CbGeAlD
Roflumilast—PDE4B—cerebellum—attention deficit hyperactivity disorder	0.023	0.0372	CbGeAlD
Roflumilast—PDE4C—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.0192	0.0501	CbGpPWpGaD
Roflumilast—PDE4B—brain—attention deficit hyperactivity disorder	0.0187	0.0302	CbGeAlD
Roflumilast—PDE4D—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.0167	0.0436	CbGpPWpGaD
Roflumilast—PDE4A—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.0159	0.0415	CbGpPWpGaD
Roflumilast—PDE4B—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.0147	0.0384	CbGpPWpGaD
Roflumilast—PDE4C—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.0108	0.0282	CbGpPWpGaD
Roflumilast—PDE4D—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00941	0.0246	CbGpPWpGaD
Roflumilast—PDE4A—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00896	0.0234	CbGpPWpGaD
Roflumilast—PDE4B—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00829	0.0216	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00599	0.0156	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00544	0.0142	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00522	0.0136	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00497	0.013	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00474	0.0124	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00459	0.012	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00451	0.0118	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00417	0.0109	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00402	0.0105	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00394	0.0103	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00365	0.00952	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00358	0.00933	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0035	0.00913	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00343	0.00894	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00333	0.00869	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00326	0.00851	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00321	0.00839	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00318	0.00829	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00311	0.00812	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00308	0.00804	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00302	0.00789	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00302	0.00788	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00296	0.00773	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.0028	0.0073	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.0028	0.0073	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00274	0.00715	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00273	0.00712	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00266	0.00695	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00251	0.00655	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00248	0.00647	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00246	0.00643	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00239	0.00622	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00238	0.0062	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00226	0.0059	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00222	0.00579	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00218	0.0057	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00217	0.00565	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00216	0.00563	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00216	0.00563	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00215	0.0056	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00211	0.00551	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00211	0.00551	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00209	0.00546	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00209	0.00544	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00208	0.00543	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00208	0.00542	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00207	0.0054	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00205	0.00536	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00201	0.00525	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00198	0.00516	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00195	0.00509	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00194	0.00507	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00193	0.00504	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00192	0.00502	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00192	0.005	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.0019	0.00496	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00189	0.00494	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00189	0.00492	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00188	0.0049	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00187	0.00488	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00184	0.0048	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00184	0.0048	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00184	0.00479	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00183	0.00477	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00182	0.00474	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.0018	0.0047	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.0018	0.00468	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00179	0.00466	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00178	0.00464	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00176	0.0046	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00175	0.00457	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00175	0.00457	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00175	0.00456	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00173	0.00451	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00172	0.00448	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.0017	0.00444	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.0017	0.00443	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00169	0.00441	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00167	0.00435	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00167	0.00435	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00166	0.00433	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00165	0.00431	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00165	0.0043	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00165	0.0043	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00162	0.00423	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00162	0.00422	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00162	0.00422	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00161	0.0042	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.0016	0.00417	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00159	0.00414	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00159	0.00414	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00157	0.00409	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00154	0.00403	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00154	0.00401	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.0015	0.0039	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00149	0.00389	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00147	0.00384	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00146	0.00382	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00146	0.00381	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00145	0.00379	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00136	0.00355	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00135	0.00353	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00128	0.00334	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00127	0.00333	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00124	0.00322	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00121	0.00317	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00119	0.0031	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00118	0.00309	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00115	0.00301	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00113	0.00295	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00113	0.00294	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00112	0.00293	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00112	0.00292	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00111	0.00291	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00108	0.00281	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00106	0.00277	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00104	0.00272	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00104	0.00272	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00104	0.0027	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00102	0.00267	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.001	0.00262	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000986	0.00257	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000986	0.00257	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000981	0.00256	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000974	0.00254	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000955	0.00249	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000947	0.00247	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000939	0.00245	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000927	0.00242	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000912	0.00238	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000907	0.00237	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000884	0.0023	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000868	0.00227	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000864	0.00225	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000858	0.00224	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000799	0.00208	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00073	0.0019	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000635	0.00166	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000605	0.00158	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00056	0.00146	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000387	0.00101	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000337	0.000878	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.00032	0.000836	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000296	0.000773	CbGpPWpGaD
